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Summary The effect of sodium butyrate on mouse and human melanoma cell lines was evaluated. Sodium
butyrate (0.1-2mM) is shown to reduce the clonogenic potential of several melanoma cell lines. The anti-
proliferative effect of sodium butyrate is accompanied by a marked increase in the activity of the plasma-
membrane bound enzyme y-glutamyl transpeptidase. Sodium butyrate treated cells acquire a well developed
rough endoplasmic reticulum and accumulate fat droplets. The development of the endoplasmic reticulum is
associated with a marked increase in the activity of the enzyme marker NADPH cytochrome c reductase. It is
suggested that the phenotypic alterations induced by sodium butyrate may serve as markers for the action of
this agent on melanoma cells and other tumours.
Butyric acid, a natural four carbon fatty acid, is known as
an inducer of differentiation in Friend erythroleukaemic cells
(Leder & Leder, 1975; Reeves & Cserjesi, 1979). In vivo
application of sodium butyrate to a child with acute
myelogenous leukaemia resulted in a partial remission
(Novogrodsky et al., 1983).
Butyric acid (or its sodium salt) also induce phenotypic
alterations in a variety of solid tumour cell lines such as
Hela cells (Fishman et al., 1974; Gosh & Cox, 1976),
neuroblastoma (Prasad, 1979; Rama & Prasad, 1984), breast
cancer cells (Abe & Kufe, 1984; Stevens et al., 1984,
colorectal carcinoma (Dexter et al., 1981; Kim et al., 1980;
Hertz & Halwer, 1982) and retinoblastoma (Kyritsis et al.,
1984). The anti-tumour effects of sodium butyrate that
include growth inhibition and decrease in tumorigenicity (for
review see Prasad, 1980; Wright, 1973; Leavitt et al., 1978;
Reese et al., 1985; Nordenberg et al., 1986a,b) are
accompanied by changes in enzyme activities (Simmons et
al., 1975; Prasad, 1980; Dexter et al., 1981; Prager & Kanar,
1984), receptor content (Fishman & Atikkan, 1979;
Jahangeer et al., 1982) and histone structure (Sealy &
Chulkley, 1978; Rubenstein et al., 1979).
We have recently shown that sodium butyrate markedly
inhibits B16 mouse melanoma cell growth and alters the
morphologic appearance of these cells. Growth inhibition
was accompanied by a marked inhibition of tyrosinase
activity (Nordenberg et al., 1986a).
In the present study we further evaluate the effects of
sodium butyrate on mouse melanoma cells and expand our
studies to human malignant melanoma cells. Sodium
butyrate is shown to inhibit clonogenicity of the different
melanoma cells in soft agar. This anti-proliferative effect of
sodium butyrate is associated with a marked increase in the
activities of the plasma membrane bound enzyme y-glutamyl
transpeptidase and NADPH cytochrome c reductase, a
marker of the well developed endoplasmic reticulum.
These phenotypic alterations may serve as markers for
butyrate activity on melanoma cells in basic and clinical
studies.
Materials and methods
Cell lines
B16 F-10 mouse melanoma cells were kindly provided by Dr
A. Raz, The Weizmann Institute, Rehovot Israel. SKMEL-
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28, human melanoma cells, were obtained from American
Type Culture Collection, Maryland, USA. 6/84 human
melanoma cells were kindly provided by Dr A. Adler from
the Immunology/Oncology Laboratory Unit, Beilinson
Medical Center, Israel. These cells were obtained from a
metastatic lesion from a lymph node of a melanoma patient.
These cells were more than 90% P-97 positive and expressed
HLA-DR antigen. The cells were grown in culture for over 2
years.
Cell culture procedure
The cells were cultured in RPMI-1640 supplemented with
10% foetal calf serum and antibiotics, in a humidified
atmosphere (5% C02, 95% air) at 37°C. For passage, cells
were detached with trypsin EDTA (Biological Industries).
Cells were passaged 2-3 times weekly.
Clonogenic assay
The effect of sodium butyrate on the clonogenic potential of
the melanoma cells was investigated by a modification
(Eliason et al., 1984) of the soft agar method of Hamburger
and Salmon (1977). Briefly, 5 x 103 single and viable cells in
I ml RPMI medium containing 10% foetal calf serum and
0.3% agar were plated as a single layer in 30mm bacterial
dishes (Sterilin). In one group of experiments the various
concentrations of sodium butyrate were dispersed in the agar
layer. In the second group of experiments cells were grown
as a monolayer on tissue culture dishes, pretreated with
sodium butyrate at various concentrations for 4 days, and
then detached and plated in soft agar as above. Viability of
the cells was assessed by the trypan blue exclusion test.
Sodium butyrate was not included in the soft agar. The
plates were incubated at 37°C in (5% C02, 95% air)
humidified atmosphere and the colonies were scored after 14
days.
Extraction and determination ofenzyme activities
About 106 cells were incubated in 10ml culture medium in
the presence and absence of sodium butyrate for 3-4 days.
For extraction of y-glutamyl transpeptidase, plates were
briefly washed with cold PBS. Cells from 1-2 plates (3-
Sx 106 cells) were scraped with a rubber policemen and
dispersed in 0.5ml TRIS-HC1 buffer (O.IM, pH=8),
containing 0.15 MNaCl. y-Glutamyl transpeptidase was
determined with L-y-glutamyl p-nitro anilide as previously
described (Novogrodsky et al., 1976; Tate & Meister, 1974).
Enzyme activity was expressed as ,umol product (p-nitro
anilide) formed h-1 mg- 1 DNA. DNA was measured in cell
lysates by the method of Burton (1956). Lysates were
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prepared by repeated freezing and thawing of the cell
suspensions.
For determination of NADPH cytochrome c reductase
-3 x 106 cells were washed with cold PBS, scraped with a
rubber policeman and placed in glass tubes. Extracts were
prepared by repeated (3 times) freezing and thawing of
1.5 x 106 cells in 0.1 ml TRIS-HCl buffer (pH7.4, 0.1 M)
containing MgCl (1 mM) and CaCl2 (1 mM). Enzyme activity
was determined spectrophotometrically at 30°C as described
by Phillips and Langdon (1962) using 2,6 dichlorophenol-
indophenol as electron acceptor. Enzyme activity was
expressed as nmol acceptor reduced min- mg- DNA.
Transmission electron microscopy
Cells were washed with cold phosphate buffered saline,
scraped with a rubber policeman and fixed in 2% glutaral-
dehyde. The cells were stained with uranyl acetate, postfixed
in osmium tetroxide, dehydrated in graded alcohol solutions
and embbed in Epon (812). Thin sections were cut with a
LKB ultratome III and examined with a Jeol lOOc-
transmission electron microscope (Glauert, 1973).
Lipid staining
Cell culture dishes were washed with PBS, fixed overnight
with formol-calcium and stained by the Oil Red 0 method
(Pearse, 1968). The stained cell cultures were covered with
cover slips using the glycerine jelly mount.
Results
The effect of sodium butyrate on the cloning efficiency in
soft agar of mouse and human melanoma cell lines is
depicted in Figure 1. The results indicate that sodium
butyrate at 1 mM completely inhibits the ability of the three
types of melanoma cells to form colonies in soft agar.
Concentrations of 0.1-0.5mm have a marked inhibitory
effect on clonogenicity in soft agar. It should be noted that
sodium butyrate at these concentrations does not affect cell
viability. Pre-treatment of the human melanoma cells with
sodium butyrate prior to culturing them in the soft agar
reduces the capacity of the cells to form colonies (Table I).
These data suggest that sodium butyrate reduces the
malignant potential of the cells. The present data are in
accordance with our previous finding that pre-treatment of
B16 FlO mouse melanoma cells with sodium butyrate prior
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Figure 1 The inhibitory effect of sodium butyrate on
clonogenicity in soft agar of mouse and human melanoma cell
lines. EO =untreated cells. O =sodium butyrate-treated cells
(0.1-1.0mM). Cells were incubated as described in Materials
and methods. Values are means of 6 plates+s.d. Statistical
significance was evaluated by paired t test. 0.25mM butyrate vs.
control P<0.02, 0.5 and 1 mM butyrate vs. control P<0.001.
Table I The effect of sodium butyrate pretreatment
on clonogenicity of human melanoma cell lines in
semi-solid medium
Number ofcolonies/dish
Pretreatment SKMEL-28 6/84
None 904+ 195 1033+470
Sodium butyrate
(0.5mM) 556+162 756+145
Sodium butyrate
(1 mM) 157+ 75b 408+ 68a
Sodium butyrate
(2mM) 54+ 62b 294+ 28b
Cells were pre-treated with sodium butyrate for 96h
prior to plating in semi solid agar. 5 x 103 viable cells
were plated as described in methods. Colonies were
scored 14 days later. Values are means+s.d. for 3
experiments (6 plates). Paired t test was performed.
Treated cells vs. untreated cells (none) ap<0.05,
bP<0.02.
to their inoculation in syngeneic C57/Bl mice resulted in a
delay of tumour appearance (Nordenberg et al., 1986a).
The anti-proliferative effect of sodium butyrate is
accompanied by phenotypic alterations that include
morphological and biochemical changes. We measured the
activity of the plasma membrane bound enzyme y-glutamyl
transpeptidase in the three melanoma cell lines. The level of
this enzyme, that has been implicated to participate in amino
acid transport, varies in the three cell lines. Sodium butyrate
treatment, however, markedly enhances the activity of this
enzyme in all three cell lines (Figure 2). Sodium butyrate has
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Figure 2 The effect of sodium butyrate on y-glutamyl
transpeptidase activity in mouse and human melanoma cell lines.
Enzyme was extracted and measured as described in Materials
and methods. []= untreated cells. n=3 days sodium butyrate
(1.5mM)-treated cells. Values are means+s.d. for 3 independent
experiments performed in duplicate. Sodium butyrate-treated
cells vs. untreated cells. *P<0.05, **P<0.02.
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no direct effect on this enzyme and at least 24h were 6/84
required for induction of this enzyme. Twenty-four hour 1.5 **
treatment with sodium butyrate resulted in a two fold
increase in the activity of y-glutamyl transpeptidase in B16 I:
F0 melanoma cells. Three days of treatment resulted in a E
four fold increase in the activity of this enzyme (Figure 2).
We have recently shown that sodium butyrate also enhances Z
the activity of another membrane bound enzyme, alkaline
phosphatase in 6/84 human melanoma cells (Nordenberg et cm
al., 1985; 1986b). E
Transmission electron-microscopy of sodium butyrate-
treated B16 FIO melanoma cells revealed a marked 1.0 B16F-1O
development of the endoplasmic reticulum (Figure 3). The
results depicted in Figure 4 shows that NADPH cytochrome ° * 0.
c reductase, a marker enzyme of the endoplasmic reticulum
is markedly enhanced in the sodium butyrate-treated cells. SKMEL-28
Figure 3 and 5 show that sodium butyrate-treated mouse *
and human melanoma cells accumulate fat droplets. Recently E l
it has been suggested that lipid accumulation in fibroblasts,
following treatment with sodium butyrate results from
enhancement of glycerophosphate dehydrogenase activity.
This enzyme is a key enzyme for adipose differentiation
(Wawra, 1986). o05
a E
0PA ~~~~~~~~~~~0
TP,~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.
Jr ~~~~~~~~~~~~~0
C.)
Figure 4 The effect of sodium butyrate on NADPH cytoclirome
c reductase activity in mouse and human melanoma cell lines.
Enzyme was extracted and measured as described in Materials
and methods. El untreated cells. V -3 days sodium butyrate
(2mm)-treated cells. Values are means+s.d. for 5 independent
experiments. Sodium butyrate vs. untreated cells *P<0.07,
.:_p<0.001
Discussion
The anti-proliferative effect of sodium butyrate on mouse
and human melanoma cell lines (Figure 1, Table I;
Nordenberg et al., 1986a,b) is shown to be accompanied by
6-N! ~~~~~~~~~~~~~phenotypic alterations. These alterations include a marked
increase in the activities of y-glutamyl transpeptidase and
NADPH cytochrome c reductase, lipid accumulation and
development ofendoplasmic reticulum.
y-Glutamyl transpeptidase, a plasma membrane bound
enzyme, has been shown to be altered during development,
~~~ , ~~~~~ ~carcinogenesis and differentiation (Fiala et at., 1972;
Novogrodsky et at., 1976; Mohandas et at., 1984; Chen &
' d p,,. ~~~~Haskill, 1984; Chiba & Jimbow, 1986). In melanoma this
enzyme has been suggested to convert glutathione-dopa to 5-
s-cysteinyldopa Mojamdar et at., 1982). We have recently
found increased activity of y-glutamyl transpeptidase in
~~ ~* ~ ~ leukaemic cells treated with sodium butyrate in vitro and in
vivo. The elevated enzyme activity was in correlation with
""~~ '~"~ elevated differentiation markers of leukaemic cells (Rephaeli
et al., 1986). Interestingly, sodium butyrate markedly
enhances the activity of another membrane bound enzyme,
. alkaline phosphatase in human 6/84 cells (Nordenberg et al.,
1985, 1986b).
Figure 3 Transmission electron micrographs of B16 FIO mouse The marked enhancement of NADPH cytochrome c
melanoma cells. (a) Control cell (x 10000); (b) 7 days sodium reductase activity seems to reflect the development of the
butyrate-treated cell (x 17500). High mag. views of selected areas endoplasmic reticulum (Figure 4). Maturation of normal
are shown in (c) Control cell (x 22000) and (d) Sodium butyrate- melanocytes from precursor cells involves development of
treated cell ( x 27000). rough endoplasmic reticulum and golgi complexes (Beitner &496 J. NORDENBERG et al.
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Figure 5 Staining of cell cultures with Oil Red 0 for the demonstration of lipid accumulation. (a) Untreated B16 FIO mouse
melanoma cell culture (x 400); (b) 3 days sodium-butyrate (1.5mM)-treated B16 FI0 melanoma cell culture (x 400); (c) Untreated
SKMEL-28 human melanoma cells ( x200); (d) 4 days sodium-butyrate (2.0mM)-treated SKMEL-28 melanoma cells ( x200).
Wennersten, 1983; Jimbow & Vesugi, 1982. NADPH
cytochrome c reductase was recently found to be increased in
B16 melanoma cells following treatment with LiCI
(Nordenberg et al., 1987) and derivatives of dimethylthiourea
(unpublished data). These agents also inhibit melanoma cell
growth and induce several differentiated features in these
cells. It should be noted that sodium butyrate also induced a
marked increase in rough endoplasmic reticulum in lympho-
blastoid cells (Asai et al., 1984).
The present findings suggest that sodium butyrate acts as
a biological modifier with potential anti-tumour properties
on melanoma cells. It induces selective phenotypic alterations
rather than a coordinated pattern of differentiation. It is
unclear whether the enhancement of y-glutamyl transpep-
tidase, or the accumulation of lipid droplets, reflect
differentiated features. The development of the endoplasmic
reticulum and enhancement of NADPH cytochrome c
reductase activity might represent differentiated character-
istics, since normal melanocyte maturation is associated with
the development ofendoplasmic reticulum.
It has been suggested that biologically modified cancer
cells might be more sensitive towards other therapeutic
modalities (Rama & Prasad, 1984; Leith et al., 1982; Kyritsis
et al., 1984). Recently it has been reported that butyrate
enhances the synthesis of interphotoreceptor retinoid binding
protein in Y-79 human retinoblastoma cells (Kyritsis et al.,
1985). Combined treatment of these cells with sodium
butyrate resulted in synergistic anti-proliferative effects
(Kyritsis et al., 1984). We are currently testing this combined
treatment on melanoma cells. Preliminary results show
additive effects of sodium butyrate and retinoic acid.
The low toxicity of sodium butyrate and the marked anti-
proliferative effects on melanoma cells form a basis for
clinical evaluation of this agent. The increased enzyme
activities and altered ultrastructural features may serve as
markers for the action of sodium butyrate in further studies.
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